Dennis Walsh - Genasys Chief Officer
| GNSS Stock | USD 3.16 0.02 0.64% |
Insider
Dennis Walsh is Chief Officer of Genasys
| Address | 16262 West Bernardo Drive, San Diego, CA, United States, 92127 |
| Phone | 858 676 1112 |
| Web | https://genasys.com |
Dennis Walsh Latest Insider Activity
Tracking and analyzing the buying and selling activities of Dennis Walsh against Genasys stock is an integral part of due diligence when investing in Genasys. Dennis Walsh insider activity provides valuable insight into whether Genasys is net buyers or sellers over its current business cycle. Note, Genasys insiders must abide by specific rules, including filing SEC forms every time they buy or sell Genasys'shares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Dennis Walsh over a year ago Acquisition by Dennis Walsh of 30000 shares of Deciphera Pharmaceuticals subject to Rule 16b-3 | ||
Dennis Walsh over a year ago Purchase by Dennis Walsh of 11000 shares of Deciphera Pharmaceuticals |
Genasys Management Efficiency
The company has return on total asset (ROA) of (0.2312) % which means that it has lost $0.2312 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.8439) %, meaning that it created substantial loss on money invested by shareholders. Genasys' management efficiency ratios could be used to measure how well Genasys manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.93 in 2025. Return On Capital Employed is likely to drop to -0.63 in 2025. At this time, Genasys' Asset Turnover is comparatively stable compared to the past year.Similar Executives
| Showing other executives | INSIDER Age | ||
| Chuck Ravetto | Novanta | N/A | |
| Antonio Gonzalez | ESCO Technologies | N/A | |
| David Schatz | ESCO Technologies | 60 | |
| Rebecca Dunn | Spectris plc | N/A | |
| Ben Bryson | Spectris plc | N/A | |
| Steven Cantor | Vishay Precision Group | N/A | |
| Deborah Boniske | ESCO Technologies | N/A | |
| Sheryl Hopkins | Badger Meter | 57 | |
| Bruce Butler | ESCO Technologies | 64 | |
| Matthew Stuyvenberg | Badger Meter | 38 | |
| Simon Pontin | Itron Inc | N/A | |
| Oded Sherman | Vishay Precision Group | 56 | |
| Sharmistha Dubey | Fortive Corp | 50 | |
| Mark Fleiner | Spectris plc | N/A | |
| Peter Dansky | Mesa Laboratories | 63 | |
| Sejal Gulati | Vishay Precision Group | N/A | |
| Garrett Krushefski | Mesa Laboratories | N/A | |
| Christopher Mulhall | Fortive Corp | 51 | |
| MSc MA | Spectris plc | 60 | |
| Daniel Comas | Fortive Corp | 56 | |
| Steven Klausner | Vishay Precision Group | 67 | |
Management Performance
| Return On Equity | -0.84 | ||||
| Return On Asset | -0.23 |
Genasys Leadership Team
Elected by the shareholders, the Genasys' board of directors comprises two types of representatives: Genasys inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Genasys. The board's role is to monitor Genasys' management team and ensure that shareholders' interests are well served. Genasys' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Genasys' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Karen Bowling, VP Marketing | ||
| Satya Chillara, Investor Officer | ||
| Dennis Klahn, CFO Secretary | ||
| Brian Harvey, Director Markets | ||
| Brian CFA, Senior Development | ||
| Dennis Walsh, Chief Officer | ||
| Richard Danforth, CEO Director |
Genasys Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Genasys a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.84 | ||||
| Return On Asset | -0.23 | ||||
| Profit Margin | (1.09) % | ||||
| Operating Margin | (0.75) % | ||||
| Current Valuation | 144.49 M | ||||
| Shares Outstanding | 44.93 M | ||||
| Shares Owned By Insiders | 3.81 % | ||||
| Shares Owned By Institutions | 52.55 % | ||||
| Number Of Shares Shorted | 789.25 K | ||||
| Price To Earning | 158.50 X |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Genasys Stock Analysis
When running Genasys' price analysis, check to measure Genasys' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genasys is operating at the current time. Most of Genasys' value examination focuses on studying past and present price action to predict the probability of Genasys' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genasys' price. Additionally, you may evaluate how the addition of Genasys to your portfolios can decrease your overall portfolio volatility.